Skip to content

Observation on the effect of Ampelopsis Compound Gel compound on the postoperative wound after anal fistula surgery

Observation on the effect of Ampelopsis Compound Gel compound on the postoperative wound after anal fistula surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000543
Enrollment
Unknown
Registered
2024-10-14
Start date
2023-11-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative trauma of anal fistula

Interventions

ointment group:Ampelopsis Ointment
Rejuvenate Liquid group:Rejuvenate Liquid
Compound Gel Group:Ampelopsis Compound Gel

Sponsors

Nanjing Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine (Nanjing Hospital of Traditional Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (i) patients who met the diagnostic criteria for low simple anal fistula; Diagnostic criteria: (1) Symptoms: redness swelling heat and pain in the anus or pus overflow from the ulceration the condition is capricious and there may be systemic reaction in the acute stage. (2) Specialized examination: outside the anus can be seen ulcerated mouth or raised nodules; finger examination can be touched to the cord-like tube leading to the anus often can be touched at the inner mouth of the nodules; anoscopy can be seen at the inner mouth of the sinus sinus deep depression or mucous membrane congestion and sometimes squeezed to see the secretion from the sinus sinus overflow. (3) Classification criteria: there is only one fistula an internal and external opening and the internal opening is usually in the anal recess corresponding to the external opening and the fistula is located in the external sphincter deep below. (ii) aged between 18-65 years old regardless of gender; (iii) agreed to participate in the observation

Exclusion criteria

Exclusion criteria: 1) ulcerative colitis Crohn's tuberculosis or other unknown infections caused by specific anal fistula; 2) previous history of anal fistula and other anal surgery; 3) combination of cardiovascular cerebrovascular hepatic renal hematologic and other serious diseases psychiatric patients; 4) pregnancy and lactation; 5) allergy or allergic to the composition of the preparation of the drug; 6) the use of other drugs may affect the results of the study; 7) be participating in multi-topic research and do not want to join the study; 8) do not meet the inclusion criteria to determine the efficacy or incomplete information that affects the efficacy or safety judgment.

Design outcomes

Primary

MeasureTime frame
Wound healing rate;

Secondary

MeasureTime frame
serum fibronectin;Healing time of the wound;pain index;IL-6;Wound secretion;Growth of sarcomeres;

Countries

China

Contacts

Public ContactZheng Xueping

Nanjing Hospital of Traditional Chinese Medicine

17720866044@163.com17396209805

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026